| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 175,000 | 17,516,000 | 6.42% | ||
| 2 | CIGNA CORPORATION | 100,000 | 13,724,000 | 5.03% | ||
| 3 | SPDR S&P BIOTECH ETF | 250,000 | 12,916,000 | 4.73% | Put | |
| 4 | MEDIVATION INC | 265,000 | 12,185,000 | 4.46% | ||
| 5 | BAXTER INTL INC | 290,000 | 11,913,000 | 4.37% | ||
| 6 | ISHARES TR | 100,000 | 11,063,000 | 4.05% | Put | |
| 7 | SPDR S&P 500 ETF TR PUT | 50,000 | 10,276,000 | 3.77% | Put | |
| 8 | ZIMMER BIOMET HLDGS INC | 85,000 | 9,064,000 | 3.32% | ||
| 9 | MERCK & CO INC | 150,000 | 7,937,000 | 2.91% | ||
| 10 | BIOGEN INC | 30,000 | 7,810,000 | 2.86% | ||
| 11 | GILEAD SCIENCES INC | 85,000 | 7,808,000 | 2.86% | ||
| 12 | HCA HOLDINGS INC | 100,000 | 7,805,000 | 2.86% | ||
| 13 | ULTRAGENYX PHARMACEUTICAL INC COM | 120,000 | 7,597,000 | 2.78% | ||
| 14 | MEDTRONIC PLC | 100,000 | 7,500,000 | 2.75% | ||
| 15 | PFIZER INC | 200,000 | 5,928,000 | 2.17% | ||
| 16 | LILLY ELI & CO | 75,000 | 5,401,000 | 1.98% | ||
| 17 | AMGEN INC | 35,000 | 5,248,000 | 1.92% | ||
| 18 | BIOGEN INC | 20,000 | 5,206,000 | 1.91% | Call | |
| 19 | TENET HEALTHCARE CORP | 175,000 | 5,063,000 | 1.86% | ||
| 20 | NUVASIVE INC COM | 100,000 | 4,865,000 | 1.78% | ||
| 21 | ONCOMED PHARMACEUTICALS INC | 467,025 | 4,722,000 | 1.73% | ||
| 22 | SUPERNUS PHARMACEUTICALS INC COM | 275,000 | 4,194,000 | 1.54% | ||
| 23 | GLOBAL BLOOD THERAPEUTICS IN COM | 250,000 | 3,965,000 | 1.45% | ||
| 24 | ALNYLAM PHARMACEUTICALS INC | 60,000 | 3,766,000 | 1.38% | ||
| 25 | BOSTON SCIENTIFIC CORP | 200,000 | 3,762,000 | 1.38% | ||
| 26 | ALLSCRIPTS HEALTHCARE | 250,000 | 3,303,000 | 1.21% | ||
| 27 | BRISTOL MYERS SQUIBB CO | 50,000 | 3,194,000 | 1.17% | Call | |
| 28 | INCYTE CORP | 40,000 | 2,899,000 | 1.06% | Call | |
| 29 | ADAMAS PHARMACEUTICALS INC | 200,000 | 2,892,000 | 1.06% | ||
| 30 | REGENERON PHARMACEUTICALS INC | 7,500 | 2,703,000 | 0.99% | Put | |
| 31 | REGENERON PHARMACEUTICALS | 7,500 | 2,703,000 | 0.99% | ||
| 32 | DYNAVAX TECHNOLOGIES CORP | 140,000 | 2,694,000 | 0.99% | ||
| 33 | MERCK & CO INC | 50,000 | 2,646,000 | 0.97% | Put | |
| 34 | BIOMARIN | 30,000 | 2,474,000 | 0.91% | ||
| 35 | KITE PHARMA INCORPORATED | 50,000 | 2,296,000 | 0.84% | ||
| 36 | HEALTHWAYS INC | 225,000 | 2,270,000 | 0.83% | ||
| 37 | COHERUS BIOSCIENCES INC COM | 100,000 | 2,123,000 | 0.78% | ||
| 38 | GLAUKOS CORP | 125,000 | 2,108,000 | 0.77% | ||
| 39 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 2,033,000 | 0.74% | ||
| 40 | BROOKDALE SR LIVING INC | 125,000 | 1,985,000 | 0.73% | ||
| 41 | ACCELERON PHARMA | 75,000 | 1,979,000 | 0.73% | ||
| 42 | GW PHARMACEUTICALS PLC | 25,000 | 1,804,000 | 0.66% | Call | |
| 43 | ACCELERATE DIAGNOSTICS INC | 125,000 | 1,796,000 | 0.66% | ||
| 44 | MEDIVATION INC | 35,000 | 1,609,000 | 0.59% | Call | |
| 45 | IMPAX LABORATORIES INC | 50,000 | 1,601,000 | 0.59% | ||
| 46 | SPECTRANETICS CORP | 110,000 | 1,597,000 | 0.59% | ||
| 47 | ALNYLAM PHARMACEUTICALS INC | 25,000 | 1,569,000 | 0.57% | Put | |
| 48 | MAZOR ROBOTICS LTD | 125,000 | 1,555,000 | 0.57% | ||
| 49 | DERMIRA INC | 75,000 | 1,551,000 | 0.57% | ||
| 50 | LDR HLDG CORP COM | 60,000 | 1,529,000 | 0.56% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000018, filed 2016.05.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
